13,357 reports of this reaction
3.1% of all DULOXETINE HYDROCHLORIDE reports
#4 most reported adverse reaction
HEADACHE is the #4 most commonly reported adverse reaction for DULOXETINE HYDROCHLORIDE, manufactured by Eli Lilly and Company. There are 13,357 FDA adverse event reports linking DULOXETINE HYDROCHLORIDE to HEADACHE. This represents approximately 3.1% of all 434,529 adverse event reports for this drug.
Patients taking DULOXETINE HYDROCHLORIDE who experience headache should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HEADACHE is moderately reported among DULOXETINE HYDROCHLORIDE users, representing a notable but not dominant share of adverse events.
In addition to headache, the following adverse reactions have been reported for DULOXETINE HYDROCHLORIDE:
The following drugs have also been linked to headache in FDA adverse event reports:
HEADACHE has been reported as an adverse event in 13,357 FDA reports for DULOXETINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
HEADACHE accounts for approximately 3.1% of all adverse event reports for DULOXETINE HYDROCHLORIDE, making it a notable side effect.
If you experience headache while taking DULOXETINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.